Back
Expeditors International of Washington Vs. Novo Nordisk AS Industry Stock Comparison
Sell
26
EXPD
Expeditors International of Washington
Last Price:
$111.35
Seasonality Move:
5.76%
Sell
11
NONOF
Novo Nordisk AS
Last Price:
$87.25
Seasonality Move:
8.64%
Sell
26
Expeditors International of Washington (EXPD)
is a Sell
Is Expeditors International of Washington a Buy, Sell or Hold?
-
The current Expeditors International of Washington [EXPD] share price is $111.28. The Score for EXPD is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
EXPD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
11
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $87.25. The Score for NONOF is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
EXPD Stock Price Chart
What is Expeditors International of Washington's stock price today?
-
The Expeditors International of Washington share price today is $111.28Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EXPD is experiencing buying pressure, which is a positive indicator for future bullish movement.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $87.25Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing selling pressure, which indicates risk of future bearish movement.
EXPD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.59 | Sell |
Relative Strength Index (14 RSI): | 31.85 | Sell |
Chaikin Money Flow: | 441590 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (111.76 - 120.74) | Sell |
Bollinger Bands (100): | (116.42 - 124.44) | Sell |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.11 | Sell |
Relative Strength Index (14 RSI): | 32.46 | Sell |
Chaikin Money Flow: | -24249 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (89.97 - 111.39) | Sell |
Bollinger Bands (100): | (101.47 - 130.27) | Sell |
EXPD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 110.91 | Buy |
20-day SMA: | 114.98 | Sell |
50-day SMA: | 118.13 | Sell |
200-day SMA: | 120.21 | Sell |
8-day EMA: | 111.48 | Sell |
20-day EMA: | 114.05 | Sell |
50-day EMA: | 117.26 | Sell |
200-day EMA: | 119.81 | Sell |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 86.94 | Buy |
20-day SMA: | 98.73 | Sell |
50-day SMA: | 104.27 | Sell |
200-day SMA: | 124.31 | Sell |
8-day EMA: | 88.93 | Sell |
20-day EMA: | 95.33 | Sell |
50-day EMA: | 103.73 | Sell |
200-day EMA: | 115.63 | Sell |
Expeditors International of Washington Earnings Growth & EXPD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and an increase next year of $0.37 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Expeditors International of Washington Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |